“…This agreed with previous studies by Asgarali, et al (2007), Karatepe, et al (2009), Kouam, et al (2010a, Grandi, et al A c c e p t e d M a n u s c r i p t (2011), Mujica, et al (2011), Cantu-Martinez, et al (2012), Steinman, et al (2012), Farkas, et al (2013 and Gizachew, et al (2013). The result, however, disagreed with reports by Shkap, et al (1998) (T. equi seroprevalence 33.7%, 95% CI: 28.9-38.7, n=361) and Ruegg, et al (2007) (T. equi seroprevalence 78.8%, 95% n=510).…”